The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 15 Mar 2005
doi: 10.1242/jcs.01729
Research Article
Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2
Ulla Henriksen,
Ulrik Gether,
and
Thomas Litman*
* Author for correspondence (e-mail: tlitman{at}binf.ku.dk)
The ATP binding cassette (ABC) half-transporter ABCG2 (MXR/BCRP/ABCP) is associated with mitoxantrone resistance accompanied by cross-resistance to a broad spectrum of cytotoxic drugs. Here we investigate the functional consequences of mutating a highly conserved lysine in the Walker A motif of the nucleotide binding domain (NBD) known to be critical for ATP binding and/or hydrolysis in ABC transporters. The mutant (ABCG2-K86M) was inactive as expected but was expressed at similar levels as the wild-type (wt) protein. The mutation did not affect the predicted oligomerization properties of the transporter; hence, co-immunoprecipitation experiments using differentially tagged transporters showed evidence for oligomerization of both ABCG2-wt and of ABCG2-wt with ABCG2-K86M. We also obtained evidence that both ABCG2-wt and ABCG2-K86M exist in the cells as disulfide-linked dimers. Moreover, measurement of prazosin-stimulated ATPase activity revealed a dominant-negative effect of ABCG2-K86M on ABCG2-wt function in co-transfected HEK293 cells. This is consistent with the requirement for at least two active NBDs for transporter activity and suggests that the transporter is a functional dimer. Finally, we analyzed targeting of ABCG2-wt and ABCG2-K86M and observed that they localize to two distinct subcellular compartments: ABCG2-wt targets the cell surface whereas ABCG2-K86M is targeted to the Golgi apparatus followed by retrieval to the endoplasmic reticulum. This suggests an as yet unknown role of the NBDs in assisting proper surface targeting of ABC transporters.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
Y. Xie, K. Xu, D. E. Linn, X. Yang, Z. Guo, H. Shimelis, T. Nakanishi, D. D. Ross, H. Chen, L. Fazli, et al.
The 44-kDa Pim-1 Kinase Phosphorylates BCRP/ABCG2 and Thereby Promotes Its Multimerization and Drug-resistant Activity in Human Prostate Cancer Cells
J. Biol. Chem.,
February 8, 2008;
283(6):
3349 - 3356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-P. Wu, S. Shukla, A. M. Calcagno, M. D. Hall, M. M. Gottesman, and S. V. Ambudkar
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter
Mol. Cancer Ther.,
December 1, 2007;
6(12):
3287 - 3296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wang, F. Sun, D.-w. Zhang, Y. Ma, F. Xu, J. D. Belani, J. C. Cohen, H. H. Hobbs, and X.-S. Xie
Sterol Transfer by ABCG5 and ABCG8: IN VITRO ASSAY AND RECONSTITUTION
J. Biol. Chem.,
September 22, 2006;
281(38):
27894 - 27904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Joshi, A. K. Pandey, N. Capite, S. M. Fortune, E. J. Rubin, and C. M. Sassetti
Characterization of mycobacterial virulence genes through genetic interaction mapping
PNAS,
August 1, 2006;
103(31):
11760 - 11765.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Saini, N. A. Gaur, and R. Prasad
Chimeras of the ABC drug transporter Cdr1p reveal functional indispensability of transmembrane domains and nucleotide-binding domains, but transmembrane segment 12 is replaceable with the corresponding homologous region of the non-drug transporter Cdr3p.
Microbiology,
May 1, 2006;
152(Pt 5):
1559 - 1573.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Henriksen, J. U. Fog, T. Litman, and U. Gether
Identification of Intra- and Intermolecular Disulfide Bridges in the Multidrug Resistance Transporter ABCG2
J. Biol. Chem.,
November 4, 2005;
280(44):
36926 - 36934.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
